Flag of the European Union EU Clinical Trials Register Help

Clinical trials for ameluz

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44396   clinical trials with a EudraCT protocol, of which   7408   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    16 result(s) found for: ameluz. Displaying page 1 of 1.
    EudraCT Number: 2019-003150-86 Sponsor Protocol Number: V1.0 Start Date*: 2019-09-20
    Sponsor Name:Royal Cornwall Hospitals NHS Trust
    Full Title: A Study to Investigate the Effect of Different Durations of Ameluz Application on Response to Treatment of Acral Actinic Keratoses
    Medical condition: Actinic keratoses
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (GB - no longer in EU/EEA)
    Trial results: View results
    EudraCT Number: 2015-000265-32 Sponsor Protocol Number: Q282dnro3/2015 Start Date*: 2015-04-08
    Sponsor Name:Janne Räsänen
    Full Title: Daylight photodynamic therapy for actinic keratoses: a multicentre study comparing two photosensitizers (BF-200 ALA versus MAL)
    Medical condition: Actinic keratosis
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FI (Completed)
    Trial results: (No results available)
    EudraCT Number: 2014-002746-50 Sponsor Protocol Number: Q272dnro47/2014 Start Date*: 2014-09-19
    Sponsor Name:Mari Salmivuori
    Full Title: Superficial basal cell cancer's photodynamic therapy: comparing three photosensitises: hexylaminolevulinate versus methylaminolevulinate and aminolevulinic acid nano emulsion versus methylaminolev...
    Medical condition: Superficial basal cell carcinoma
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FI (Completed)
    Trial results: (No results available)
    EudraCT Number: 2015-004382-83 Sponsor Protocol Number: ALA-AK-CT009 Start Date*: 2016-06-09
    Sponsor Name:Biofrontera Bioscience GmbH
    Full Title: A randomized, observer-blind, intra-individual phase III study to evaluate the safety and efficacy of BF 200 ALA (Ameluz®) in combination with daylight-PDT (photodynamic therapy) in comparison with...
    Medical condition: Actinic keratosis
    Disease: Version SOC Term Classification Code Term Level
    18.1 10040785 - Skin and subcutaneous tissue disorders 10000614 Actinic keratosis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) ES (Completed)
    Trial results: View results
    EudraCT Number: 2013-002108-15 Sponsor Protocol Number: no_nbr Start Date*: 2013-06-05
    Sponsor Name:Mari Grönroos
    Full Title: Treating actinic keratoses with natural daylight PDT: comparing two light sensitizers (ALA vs. MAL)
    Medical condition: actinic keratoses of the face or scalp
    Disease: Version SOC Term Classification Code Term Level
    16.0 10040785 - Skin and subcutaneous tissue disorders 10000614 Actinic keratosis PT
    Population Age: Elderly Gender: Male, Female
    Trial protocol: FI (Completed)
    Trial results: (No results available)
    EudraCT Number: 2017-000486-72 Sponsor Protocol Number: ALA-AK-CT010 Start Date*: 2017-07-28
    Sponsor Name:Biofrontera Bioscience GmbH
    Full Title: A randomized, double-blind, intra-individual, multi-center phase III study to evaluate the safety and efficacy of BF 200 ALA (Ameluz®) versus placebo in the treatment of mild to severe actinic kera...
    Medical condition: Actinic keratosis (AK)
    Disease: Version SOC Term Classification Code Term Level
    20.0 10040785 - Skin and subcutaneous tissue disorders 10000614 Actinic keratosis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2013-002510-12 Sponsor Protocol Number: ALA-AK-CT007 Start Date*: 2013-08-27
    Sponsor Name:Biofrontera Bioscience GmbH
    Full Title: A randomized, double-blind, phase III multi-center study to evaluate the safety and efficacy of BF-200 ALA (Ameluz®) versus placebo in the field-directed treatment of mild to moderate actinic kerat...
    Medical condition: Actinic keratosis (AK)
    Disease: Version SOC Term Classification Code Term Level
    16.0 10040785 - Skin and subcutaneous tissue disorders 10000614 Actinic keratosis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2014-001440-38 Sponsor Protocol Number: 42647 Start Date*: 2014-05-22
    Sponsor Name:Department of Dermatology D92, Bispebjerg Hospital
    Full Title: Methods to increase PpIX formation in the skin of healthy volunteers
    Medical condition: Healthy volunteers - no medical condition is investigated but pharmaco kinetics
    Disease: Version SOC Term Classification Code Term Level
    17.0 10022891 - Investigations 10040879 Skin investigations HLGT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: (No results available)
    EudraCT Number: 2015-004111-20 Sponsor Protocol Number: Q291dnro62/2015 Start Date*: 2016-01-12
    Sponsor Name:Janne Räsänen
    Full Title: Photodynamic therapy for Lentigo maligna with 5-aminolaevulinic acid nanoemulsion (BF-200 ALA)
    Medical condition: Lentigo maligna
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FI (Completed)
    Trial results: (No results available)
    EudraCT Number: 2014-003331-18 Sponsor Protocol Number: PDTBG2 Start Date*: 2014-12-17
    Sponsor Name:Medizinische Universität Wien, univ. Klinik f. Dermatologie
    Full Title: The influence of occlusive application of 5-aminolaevulinic acid (ALA) on the efficacy of photodynamic therapy for actinic keratosis
    Medical condition: non melanoma skin cancer
    Disease: Version SOC Term Classification Code Term Level
    17.1 10040785 - Skin and subcutaneous tissue disorders 10000614 Actinic keratosis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Completed)
    Trial results: View results
    EudraCT Number: 2015-002537-22 Sponsor Protocol Number: PDT-PR1 Start Date*: 2017-01-25
    Sponsor Name:Medizinische Universität Wien, Univ. Klinik f. Dermatologie
    Full Title: Photodynamic therapy for skin rejuvenation: A pilotstudy evaluating the effectiveness of 5-aminolevulinic acid -based photodynamic therapy in the treatment of photodamaged skin
    Medical condition: Photodamaged skin
    Disease: Version SOC Term Classification Code Term Level
    19.1 10040785 - Skin and subcutaneous tissue disorders 10068388 Actinic elastosis PT
    19.1 10040785 - Skin and subcutaneous tissue disorders 10000614 Actinic keratosis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Completed)
    Trial results: View results
    EudraCT Number: 2013-004228-12 Sponsor Protocol Number: PDTZ01 Start Date*: 2014-09-26
    Sponsor Name:Medizinische Universität Wien, univ. Klinik f. Dermatologie
    Full Title: Enhanced efficacy of photodynamic therapy in combination with 3,75% imiquimod - a randomised, prospective , observer-blinded study in patients with actinic keratosis
    Medical condition: non melanoma skin cancer
    Disease: Version SOC Term Classification Code Term Level
    17.0 10040785 - Skin and subcutaneous tissue disorders 10000614 Actinic keratosis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2015-002245-66 Sponsor Protocol Number: PDTZ02 Start Date*: 2015-12-30
    Sponsor Name:Medizinische Universität Wien, Univ. Klinik f. Dermatologie
    Full Title: Impact of light dose on the efficacy of Photodynamic therapy with 5-aminolaevulinic acid (5-ALA) and a 635 +- 9nm emitting LED-lamp for the treatment of actinic keratoses - a randomized, observer-b...
    Medical condition: Actinic keratoses (AK) as precursors of squamous cell carcinoma (SCC) of the skin
    Disease: Version SOC Term Classification Code Term Level
    19.0 10040785 - Skin and subcutaneous tissue disorders 10000614 Actinic keratosis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2017-003626-32 Sponsor Protocol Number: PDT-PR2 Start Date*: 2018-02-06
    Sponsor Name:Medizinische Universität Wien, Univ. Klinik f. Dermatologie
    Full Title: Photodynamic therapy (pdt) for skin rejuvenation: A pilotstudy evaluating the effectiveness of two modalities of photodynamic therapy in the treatment of photodamaged skin
    Medical condition: Photodamaged skin
    Disease: Version SOC Term Classification Code Term Level
    20.0 10040785 - Skin and subcutaneous tissue disorders 10068388 Actinic elastosis PT
    20.0 10040785 - Skin and subcutaneous tissue disorders 10000614 Actinic keratosis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2013-003241-42 Sponsor Protocol Number: ALA-BCC-CT008 Start Date*: 2013-12-23
    Sponsor Name:Biofrontera Bioscience GmbH
    Full Title: A randomized, observer blind, multinational phase III study to evaluate the safety and efficacy of BF-200 ALA (Ameluz®) in comparison to Metvix® in the treatment of non-aggressive basal cell carcin...
    Medical condition: Basal cell carcinoma (BCC)
    Disease: Version SOC Term Classification Code Term Level
    20.0 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10004146 Basal cell carcinoma PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) GB (Completed)
    Trial results: View results
    EudraCT Number: 2015-002408-97 Sponsor Protocol Number: MALvsALA Start Date*: 2015-12-16
    Sponsor Name:Dr. Carlos Serra
    Full Title: Comparative Study, intraindividual to evaluate efficacy and safety of the treatment of actinic keratosis with photodinamic therapy between methyl aminolevulinate cream and aminolevulinic acid nanos...
    Medical condition: Actinic Keratosis
    Disease: Version SOC Term Classification Code Term Level
    18.0 10040785 - Skin and subcutaneous tissue disorders 10000614 Actinic keratosis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Fri Jun 05 05:22:16 CEST 2026 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA